6-Bromo-1,2,4-triazin-3-amine

We are 6-Bromo-1,2,4-triazin-3-amine CAS:69249-22-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  6-Bromo-1,2,4-triazin-3-amine
CAS.NO:   69249-22-5
Synonyms:
3-AMINO-6-BROMO-1,2,4-TRIAZINE
3-Amino-6-bromo-1,2,4-triazin
1,2,4-Triazin-3-amine,6-bromo

Molecular Formula: C3H3BrN4
Molecular Weight:  174.98700

Physical and Chemical Properties:
Density: 1.998g/cm3
Boiling point: 373.6ºC at 760 mmHg
Melting point: /
Flash point: 179.7ºC
Refractive index: 1.663

Specification:
Appearance:  Powder
Purity: >99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Storage:0°C-6°C.Stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Application:Intermediates of Benzamide CAS:1029712-80-8.

6-Bromo-1,2,4-triazin-3-amine


Related News: The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, Monophenylester The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.2- (4-clorofenil) hexanenitrilo CAS:2124-74-5 In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.

Related Products
Product Name
3,5-Difluoro-2-Methylbenzoic Acid View Details
(R,E)-5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid View Details
2,2′-Dichlorodiethyl ether View Details
5-Chloro-2-fluorophenol manufacturer octamethylcyclotetrasiloxane manufacturer 2-Bromobutane manufacturer methyl 2,3-difluoroisonicotinate manufacturer 3-(2-chloropyrimidin-4-yl)-1-methylindole manufacturer